EUVIMEDEUVIMED entdecken
Crossref

The Role of Intramolecular Reactions and Chemical Degradation in the Apparent Biotransformation Pathways of a Series of SYK Inhibitors

Beatriz Calle, Bernard Barlaam, Coura Diène, Eva Lenz, Scott Martin, Ujjal Sarkar, Stephen Wilkinson, Andy Pike iD

Drug Metabolism and Disposition · 2024

DOI: 10.1124/dmd.124.001659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024. Verfasst von Beatriz Calle und 7 weiteren Autor:innen. Beteiligte Einrichtung: DMPK (B.C., S.M., S.W., A.P.) and Medicinal Chemistry (B.B., C.D., E.L.), Oncology R&D, AstraZeneca, Cambridge, United Kingdom and DMPK, Oncology R&D…. Hauptthemen laut MEDLINE: Syk Kinase, Biotransformation, Protein-Tyrosine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vitro metabolism studies of the spleen tyrosine kinase inhibitors AZ-A and AZ-B identified four unusual metabolites. M1 (mass-to-charge ratio 411) was formed by both molecules and was common to several analogs (AZ-C to AZ-H) sharing the same core structure, appearing to derive from the complete loss of a pendent 3,4-diaminotetrahydropyran ring and pyrazole ring cleavage resulting in a nonobvious metabolite. M2-M4 were formed by AZ-A and a subset of the other compounds only and apparently resulted from a sequential loss of H2 from parent. Initial attempts to isolate M3 for identification were unsuccessful due to sample degradation, and it was subsequently found that M2 and M3 underwent sequential chemical degradation steps to M4. M4 was successfully isolated and shown by mass spectrometry and NMR spectroscopy to be a tricyclic species incorporating the pyrazole and the 3,4-diaminotetrahydropyran groups. We propose that this arises from an intramolecular reaction between the primary amine on the tetrahydropyran and a putative epoxide intermediate on the adjacent pyrazole ring, evidence for which was generated in a β-mercaptoethanol-trapping experiment. The loss of the tetrahydropyran moiety observed in M1 was found to be enhanced in an analog that was unable to undergo the intramolecular reaction step, leading us to propose two possible reaction pathways originating from the reactive intermediate. Ultimately, we conclude that the apparently complex and unusual metabolism of this series of compounds likely resulted from a single metabolic activation step forming an epoxide intermediate, which subsequently underwent intramolecular rearrangement and/or chemical degradation to form the final observed products. SIGNIFICANCE STATEMENT: The current work provides an unusual biotransformation example showing the potential for intramolecular reactions and chemical degradation to give the appearance of complex metabolism arising from a single primary route of metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Syk KinaseBiotransformationProtein-Tyrosine KinasesHumansProtein Kinase InhibitorsMicrosomes, LiverIntracellular Signaling Peptides and ProteinsPyrazoles

Substanzen

Syk KinaseProtein-Tyrosine KinasesSYK protein, humanProtein Kinase InhibitorsIntracellular Signaling Peptides and ProteinsPyrazoles

Autor:innen und Institutionen

  • DMPK (B.C., S.M., S.W., A.P.) and Medicinal Chemistry (B.B., C.D., E.L.), Oncology R&D, AstraZeneca, Cambridge, United Kingdom and DMPK, Oncology R&D, AstraZeneca, Boston, Massachusetts (U.S.).
  • DMPK (B.C., S.M., S.W., A.P.) and Medicinal Chemistry (B.B., C.D., E.L.), Oncology R&D, AstraZeneca, Cambridge, United Kingdom and DMPK, Oncology R&D, AstraZeneca, Boston, Massachusetts (U.S.) andrew.pike@astrazeneca.co…

ORCID-Profile: Andy Pike

Zitieren

APA

Calle, B., Barlaam, B., Diène, C., Lenz, E., Martin, S., Sarkar, U., Wilkinson, S., & Pike, A. (2024). The Role of Intramolecular Reactions and Chemical Degradation in the Apparent Biotransformation Pathways of a Series of SYK Inhibitors. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.124.001659

Vancouver

Calle B, Barlaam B, Diène C, Lenz E, Martin S, Sarkar U, et al. The Role of Intramolecular Reactions and Chemical Degradation in the Apparent Biotransformation Pathways of a Series of SYK Inhibitors. Drug Metabolism and Disposition. 2024. doi:10.1124/dmd.124.001659

BibTeX
@article{Calle2024,
  author = {Calle, Beatriz and Barlaam, Bernard and Diène, Coura and Lenz, Eva and Martin, Scott and Sarkar, Ujjal and Wilkinson, Stephen and Pike, Andy},
  title = {The Role of Intramolecular Reactions and Chemical Degradation in the Apparent Biotransformation Pathways of a Series of SYK Inhibitors},
  journal = {Drug Metabolism and Disposition},
  year = {2024},
  doi = {10.1124/dmd.124.001659}
}
Kostenlos starten →